STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

VYGR Form 144 filing for 5,843-share planned sale

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Voyager Therapeutics (VYGR) filed a Form 144 notice for a proposed sale of 5,843 common shares. The shares carry an aggregate market value of $27,936.55 and are slated for sale through Fidelity Brokerage Services LLC on or about 10/03/2025 on the NASDAQ.

The securities were acquired on 10/01/2025 via restricted stock vesting from the issuer as compensation. This is a routine compliance notice that permits the holder to sell these shares under Rule 144, subject to applicable volume and manner-of-sale conditions.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did VYGR disclose in this Form 144?

A proposed sale of 5,843 common shares with an aggregate market value of $27,936.55 through Fidelity Brokerage Services LLC.

When is the approximate sale date for the VYGR shares?

The notice lists an approximate sale date of 10/03/2025 on the NASDAQ.

How were the VYGR shares to be sold acquired?

They were acquired on 10/01/2025 via restricted stock vesting from the issuer as compensation.

How many VYGR shares are involved and what is the stated value?

The filing covers 5,843 shares with an aggregate market value of $27,936.55.

Which broker is handling the proposed VYGR share sale?

The broker named is Fidelity Brokerage Services LLC.

On which exchange are the VYGR shares planned to be sold?

The filing lists NASDAQ as the exchange.
Voyager Therapeutics Inc

NASDAQ:VYGR

VYGR Rankings

VYGR Latest News

VYGR Latest SEC Filings

VYGR Stock Data

224.07M
46.50M
16.52%
59.95%
5.31%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
LEXINGTON